Robert Krause - Infectious Diseases

Author Information

Robert Krause is a distinguished researcher in the field of Infectious Diseases, affiliated with the Division of Infectious Diseases, Department of Internal Medicine at the Medical University of Graz, Graz, Austria. His work primarily focuses on the clinical management and treatment of infectious diseases, with significant contributions to understanding SARS-CoV-2 and its impact on various health conditions.

Research Contributions

Robert Krause has been actively involved in research concerning the COVID-19 pandemic, particularly in the areas of drug treatment, clinical management, and immune responses. His studies have explored the efficacy of SARS-CoV-2 serology assays, the impact of COVID-19 vaccination on individuals with diabetes, and the misuse of ivermectin during the pandemic. Additionally, his research extends to the diagnosis of invasive pulmonary aspergillosis and the evaluation of natural and hybrid immunity against SARS-CoV-2 reinfections.

Aliases

Robert Krause is also known by aliases such as R Krause and R. Krause in various publications and academic circles.

Publication and Citation Metrics

Metric	Value
Total Papers	326
Total Citations	7945
H-index	51

Publications:

ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply

DOI: 10.1016/j.cmi.2021.12.025

Year: 2022

Longitudinal comparison of automated SARS-CoV-2 serology assays in assessing virus neutralization capacity in COVID-19 convalescent sera.

DOI: 10.5858/arpa.2021-0604-SA

Year: 2022

Phyllosphere-associated microbiota in built environment: Do they have the potential to antagonize human pathogens?

DOI: 10.1016/j.jare.2022.02.003

Year: 2022

Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective COVAC‐DM cohort study

DOI: 10.1111/dom.14643

Year: 2022

Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!

DOI: 10.1016/j.cmi.2022.03.022

Year: 2022

Effluent microscopy is a useful adjuvant diagnostic tool in peritoneal dialysis-associated peritonitis.

DOI: 10.5414/CN110732

Year: 2022

Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid

DOI: 10.1128/jcm.00215-22

Year: 2022

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity

DOI: 10.1016/j.envres.2022.112911

Year: 2022

Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control-the prospective COVAC-DM cohort study

DOI: 10.1101/2021.11.05.21265849

Year: 2021

Sensitivity and specificity of the antigen-based anterior nasal self-testing programme for detecting SARS-CoV-2 infection in schools, Austria, March 2021

DOI: 10.2807/1560-7917.ES.2021.26.34.2100797

Year: 2021

What Treatment Options are Available?

What is Lipid Metabolism?

What is Cervical Cancer?

When Should Antibiotics be Prescribed?

Can Condoms Be Used for All Types of Sexual Activities?

How Do Antiviral Drugs Work?

What is Artemisinin?

How are Sporozoites Transmitted?

When Should One Seek Medical Attention for Fatigue?

What Should You Discuss with Your Healthcare Provider?

Partnered Content Networks

Relevant Topics